| Description | This four-day program will cover data supporting guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and hematologic disorders. At the end of the course, physicians will leave with a comprehensive syllabus, a self-assessment, and a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors as well as hematologic disorders. There will be a case-based review session and discussions. The course can be used to help prepare attendees for certifying and re-certifying exams. |
|---|